These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 36759093)

  • 21. Best methods for identification and treatment of PCOS.
    Artini PG; Di Berardino OM; Simi G; Papini F; Ruggiero M; Monteleone P; Cela V
    Minerva Ginecol; 2010 Feb; 62(1):33-48. PubMed ID: 20186113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ACOG Practice Bulletin No. 108: Polycystic ovary syndrome.
    Obstet Gynecol; 2009 Oct; 114(4):936. PubMed ID: 19888063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New perspectives on the definition and management of polycystic ovary syndrome.
    Pasquali R; Gambineri A
    J Endocrinol Invest; 2018 Oct; 41(10):1123-1135. PubMed ID: 29363047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study.
    Zhang HY; Guo CX; Zhu FF; Qu PP; Lin WJ; Xiong J
    Arch Gynecol Obstet; 2013 Mar; 287(3):525-31. PubMed ID: 23108387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome.
    Amato MC; Galluzzo A; Merlino S; Mattina A; Richiusa P; Criscimanna A; Giordano C
    Eur J Endocrinol; 2006 Dec; 155(6):859-65. PubMed ID: 17132756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of PCOS and related hyperandrogenic traits in premenopausal women with type 1 diabetes: a systematic review and meta-analysis.
    Bayona A; Martínez-Vaello V; Zamora J; Nattero-Chávez L; Luque-Ramírez M; Escobar-Morreale HF
    Hum Reprod Update; 2022 Jun; 28(4):501-517. PubMed ID: 35237802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonalcoholic fatty liver disease and obstructive sleep apnea in women with polycystic ovary syndrome.
    Doycheva I; Ehrmann DA
    Fertil Steril; 2022 May; 117(5):897-911. PubMed ID: 35512974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Female pattern hair loss and polycystic ovarian syndrome: more than just hirsutism.
    Jiang VS; Hawkins SD; McMichael A
    Curr Opin Endocrinol Diabetes Obes; 2022 Dec; 29(6):535-540. PubMed ID: 36226726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How to Evaluate Acne in Reproductive-Age Women: An Epidemiological Study in Chinese Communities.
    Wang YY; Li SW; Luo S; Qin L; Zeng X; Li L; Li XH
    Biomed Res Int; 2019; 2019():6126808. PubMed ID: 30854398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of socio-demographic and clinical characteristics of PCOS patients attending a tertiary care institute in Colombo.
    Ranathunga I; Athukorala TG; Sumanatilleke MR; Somasundaram NP
    BMC Endocr Disord; 2022 Nov; 22(1):289. PubMed ID: 36411444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of clinical and biochemical hyperandrogenism in Thai women with polycystic ovary syndrome.
    Leerasiri P; Wongwananuruk T; Indhavivadhana S; Techatraisak K; Rattanachaiyanont M; Angsuwathana S
    J Obstet Gynaecol Res; 2016 Jun; 42(6):678-83. PubMed ID: 26890011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polycystic ovary syndrome in the pediatric population.
    Bremer AA
    Metab Syndr Relat Disord; 2010 Oct; 8(5):375-94. PubMed ID: 20939704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent maternal virilization during pregnancy in patients with PCOS: two clinical cases.
    Deknuydt M; Dumont A; Bruyneel A; Dewailly D; Catteau-Jonard S
    Reprod Biol Endocrinol; 2018 Oct; 16(1):107. PubMed ID: 30376853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome.
    Zhao X; Zhong J; Mo Y; Chen X; Chen Y; Yang D
    Int J Gynaecol Obstet; 2010 Feb; 108(2):148-51. PubMed ID: 19932893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Long-term health consequences of polycystic ovaries syndrome: metabolic, cardiovascular and oncological aspects].
    Gutman G; Geva E; Lessing JB; Amster R
    Harefuah; 2007 Nov; 146(11):889-93, 908. PubMed ID: 18087838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic features of polycystic ovary syndrome in adolescents (review).
    Beltadze K; Barbakadze L
    Georgian Med News; 2015 Jan; (238):32-4. PubMed ID: 25693210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.
    Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
    Fertil Steril; 2004 Jan; 81(1):19-25. PubMed ID: 14711538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic, hormonal and metabolic aspects of PCOS: an update.
    De Leo V; Musacchio MC; Cappelli V; Massaro MG; Morgante G; Petraglia F
    Reprod Biol Endocrinol; 2016 Jul; 14(1):38. PubMed ID: 27423183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.